Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
$3.47
+0.3%
$2.57
$1.51
$12.00
$244.81M1.992.33 million shs745,808 shs
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
$16.64
+0.3%
$19.40
$2.26
$41.72
$178.99M1.4927,653 shs3,367 shs
LifeMD, Inc. stock logo
LFMD
LifeMD
$4.68
+4.2%
$3.87
$2.56
$15.84
$222.77M2.031.17 million shs250,437 shs
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
$1.92
-0.3%
$2.05
$1.37
$4.09
$74.95M0.9251,579 shs1,642 shs
Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
-3.08%+29.10%+17.69%+52.42%+35.16%
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
-2.53%-2.47%+3.05%-51.24%+614.66%
LifeMD, Inc. stock logo
LFMD
LifeMD
-14.80%-4.06%+30.90%+42.99%-44.12%
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
+6.08%-1.03%-11.11%-23.81%-20.27%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
$3.47
+0.3%
$2.57
$1.51
$12.00
$244.81M1.992.33 million shs745,808 shs
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
$16.64
+0.3%
$19.40
$2.26
$41.72
$178.99M1.4927,653 shs3,367 shs
LifeMD, Inc. stock logo
LFMD
LifeMD
$4.68
+4.2%
$3.87
$2.56
$15.84
$222.77M2.031.17 million shs250,437 shs
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
$1.92
-0.3%
$2.05
$1.37
$4.09
$74.95M0.9251,579 shs1,642 shs
Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
-3.08%+29.10%+17.69%+52.42%+35.16%
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
-2.53%-2.47%+3.05%-51.24%+614.66%
LifeMD, Inc. stock logo
LFMD
LifeMD
-14.80%-4.06%+30.90%+42.99%-44.12%
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
+6.08%-1.03%-11.11%-23.81%-20.27%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
1.50
Reduce$6.0072.91% Upside
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
1.00
SellN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
2.67
Moderate Buy$9.1495.36% Upside
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
2.50
Moderate Buy$5.00161.10% Upside

Current Analyst Ratings Breakdown

Latest SERA, AIRS, LFMD, and BNR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/4/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Reiterated RatingBuy$10.00
4/20/2026
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
Reiterated RatingSell (D-)
3/27/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Reiterated RatingSell (E+)
3/27/2026
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
Reiterated RatingSell (D-)
3/16/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
UpgradeNeutralOutperform$6.00 ➝ $8.00
3/12/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Set Price Target$10.00
3/11/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Boost Price TargetBuy$9.00 ➝ $10.00
3/10/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Reiterated RatingOverweight
3/10/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Reiterated RatingBuy$10.00
(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
$151.82M1.61$0.02 per share200.09$1.40 per share2.48
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
$77.16M2.32N/AN/A$7.11 per share2.34
LifeMD, Inc. stock logo
LFMD
LifeMD
$194.05M1.15N/AN/A$0.48 per share9.75
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
$80K936.91N/AN/A$1.94 per share0.99
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
-$11.67M-$0.19N/AN/AN/A-7.68%-5.01%-2.19%5/8/2026 (Estimated)
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
-$7.92M-$0.79N/AN/AN/A-10.27%-9.98%-6.69%6/2/2026 (Estimated)
LifeMD, Inc. stock logo
LFMD
LifeMD
$14.35M$0.2693.6210.17N/A2.37%-176.40%-22.61%N/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-$31.93M-$0.68N/AN/AN/A-56,385.97%-39.22%-29.95%N/A

Latest SERA, AIRS, LFMD, and BNR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/2/2026Q1 2026
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
-$2.2884N/AN/AN/A$19.21 millionN/A
5/8/2026Q4 2025
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
-$0.02-$0.01+$0.01-$0.03$39.20 million$39.39 million
5/6/2026Q1 2026
LifeMD, Inc. stock logo
LFMD
LifeMD
-$0.14-$0.20-$0.06-$0.20$48.84 million$50.16 million
5/6/2026Q1 2026
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-$0.16-$0.17-$0.01-$0.17$0.07 million$0.01 million
3/31/2026Q4 2025
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
-$0.02-$0.02N/A$0.02N/A$33.44 million
3/31/2026Q4 2025
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
-$0.03$0.02+$0.05$0.02$34.93 million$33.44 million
3/18/2026Q4 2025
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-$0.17-$0.16+$0.01-$0.16$0.03 million$0.01 million
3/13/2026Q4 2025
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/A-$0.21N/A-$0.21N/A$18.05 million
3/9/2026Q4 2025
LifeMD, Inc. stock logo
LFMD
LifeMD
-$0.01-$0.04-$0.03$0.41$48.57 million$46.87 million
2/14/2026Q4 2025
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/A-$0.21N/A-$0.21N/A$18.05 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
N/AN/AN/AN/AN/A
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/AN/AN/AN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
N/AN/AN/AN/AN/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
0.58
0.55
0.55
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/A
2.99
2.79
LifeMD, Inc. stock logo
LFMD
LifeMD
N/A
1.25
1.18
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
N/A
1.69
1.69

Institutional Ownership

CompanyInstitutional Ownership
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
91.54%
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
30.03%
LifeMD, Inc. stock logo
LFMD
LifeMD
35.52%
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
54.64%

Insider Ownership

CompanyInsider Ownership
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
44.60%
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
30.30%
LifeMD, Inc. stock logo
LFMD
LifeMD
18.40%
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
11.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
24070.55 million39.08 millionOptionable
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
1,39010.76 million7.50 millionNot Optionable
LifeMD, Inc. stock logo
LFMD
LifeMD
23047.60 million38.84 millionOptionable
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
12039.14 million34.72 millionOptionable

Recent News About These Companies

Sera Prognostics Balances Cash Strength With Slow Ramp
Sera Prognostics Q1 Earnings Call Highlights
Sera Prognostics Inc.
Sera Prognostics Q4 2025 Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

AirSculpt Technologies stock logo

AirSculpt Technologies NASDAQ:AIRS

$3.47 +0.01 (+0.29%)
As of 11:06 AM Eastern
This is a fair market value price provided by Massive. Learn more.

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. The company's body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.

Burning Rock Biotech stock logo

Burning Rock Biotech NASDAQ:BNR

$16.64 +0.06 (+0.33%)
As of 10:54 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. In addition, the company provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients. Further, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. Additionally, the company offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited was incorporated in 2014 and is headquartered in Guangzhou, China.

LifeMD stock logo

LifeMD NASDAQ:LFMD

$4.68 +0.19 (+4.23%)
As of 11:06 AM Eastern
This is a fair market value price provided by Massive. Learn more.

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Sera Prognostics stock logo

Sera Prognostics NASDAQ:SERA

$1.92 -0.01 (-0.26%)
As of 10:59 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.